XML 105 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-based compensation (Tables)
12 Months Ended
Mar. 28, 2020
Stock-based compensation  
Summary of Company's restricted stock award grants

The following table summarizes the Company's restricted stock award grants during fiscal 2019, 2018, and 2017.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Performance-

 

 

 

 

 

 

 

 

 

 

 

Number of

 

 

 

Based

 

 

Total

 

 

 

 

Number of

 

 

 

Performance-

 

Performance-

 

Awards

 

 

Number of

 

 

 

 

Time-Based

 

Time-Based

 

Based

 

Based

 

that Met

 

 

Awards

 

Grant Date

 

Awards

 

Vesting

 

Awards

 

Vesting

 

Performance

Grant Date

    

Granted

    

Fair Value

    

Granted

    

Period

    

Granted

    

Period

    

Condition

December 12, 2017

 

22,191

 

$

5.52

 

4,528

 

 3

years  

17,663

(1)

 3

years  

9,011

June 1, 2018

 

551,453

 

$

7.68

 

112,553

 

 3

years  

438,900

(2)

 3

years  

205,616

September 12, 2018

 

73,264

 

$

10.92

 

73,264

 

 3

years  

 —

 

 —

years  

 —

June 1, 2019

 

605,927

 

$

7.03

 

123,667

 

 3

years  

482,260

(3)

 3

years  

182,520

August 28, 2019

 

172,792

 

$

4.63

 

172,792

 

 3

years  

 —

 

 —

years  

 —


(1)

These performance-based restricted stock awards vest based on achievement of fiscal 2017 performance targets and are also subject to time-based vesting requirements.

(2)

These performance-based restricted stock awards vest based on achievement of fiscal 2018 performance targets and are also subject to time-based vesting requirements.

(3)

These performance-based restricted stock awards vest based on achievement of fiscal 2019 performance targets and are also subject to time-based vesting requirements.

Summary of Company’s restricted stock awards activity

 

 

 

 

 

 

 

 

Restricted Stock 

 

Weighted Average 

 

    

Awards

    

Grant Date Fair Value

Nonvested at March 31, 2018

 

243,235

 

$

5.39

Granted

 

624,717

 

 

8.06

Vested

 

(70,132)

 

 

5.38

Forfeited

 

(4,372)

 

 

5.29

Withheld related to net settlement

 

(23,590)

 

 

5.38

Nonvested at March 30, 2019

 

769,858

 

$

7.56

Granted

 

778,719

 

 

6.50

Vested

 

(174,239)

 

 

7.13

Forfeited

 

(277,597)

 

 

7.75

Withheld related to net settlement

 

(55,477)

 

 

6.73

Nonvested at March 28, 2020

 

1,041,264

 

$

6.84

 

Summary of the Company's annual stock option grants

The following table summarizes the Company's annual stock option grants during fiscal 2017:

 

 

 

 

    

Number of Stock

Grant Date

 

Options Granted

September 12, 2017

 

343,352

 

Summary of the Company's stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year

 

 

 

2019

 

2018

 

2017

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Weighted-

 

average

 

 

 

 

 

Weighted-

 

average

 

 

 

 

 

Weighted-

 

average

 

 

 

 

 

 

 

average

 

contractual

 

Aggregate

 

 

 

average

 

contractual

 

Aggregate

 

 

 

average

 

contractual

 

Aggregate

 

 

 

 

 

exercise

 

term

 

intrinsic

 

 

 

exercise

 

term

 

intrinsic

 

 

 

exercise

 

term

 

intrinsic

 

 

 

 

 

price

 

remaining

 

value

 

 

 

price

 

remaining

 

value

 

 

 

price

 

remaining

 

value

 

 

    

Shares

   

(per share)

    

(years)

    

(thousands)

    

Shares

    

(per share)

    

(years)

    

(thousands)

    

Shares

    

(per share)

    

(years)

    

(thousands)

 

Beginning balance

 

2,895,539

 

$

15.27

 

 

 

 

 

 

3,040,206

 

$

15.40

 

 

 

 

 

 

2,946,028

 

$

16.81

 

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

 

 —

 

$

 —

 

 

 

 

 

 

343,352

 

$

4.10

 

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

 

 —

 

$

 —

 

 

 

 

 

 

 —

 

$

 —

 

 

 

 

 

 

Forfeited

 

(42,864)

 

$

8.83

 

 

 

 

 

 

(27,793)

 

$

18.00

 

 

 

 

 

 

(90,881)

 

$

15.13

 

 

 

 

 

 

Expired

 

(293,443)

 

$

15.98

 

 

 

 

 

 

(116,874)

 

$

17.89

 

 

 

 

 

 

(158,293)

 

$

17.31

 

 

 

 

 

 

Ending balance

 

2,559,232

 

$

15.30

 

4.27

 

$

 —

 

2,895,539

 

$

15.27

 

5.27

 

$

2,460,384

 

3,040,206

 

$

15.40

 

6.23

 

$

482

 

Vested and exercisable at end of year

 

2,389,873

 

$

15.69

 

4.16

 

$

 —

 

2,428,274

 

$

16.49

 

4.95

 

$

1,102,326

 

2,241,283

 

$

17.53

 

5.65

 

$

 7

 

 

Summary of the weighted-average assumptions used with the Black Scholes pricing model to estimate the weighted-average grant date fair value of stock options granted

 

 

 

 

 

 

 

 

 

 

Fiscal 2017

Expected term

 

6.0

years

Expected volatility

 

60.6

%

Risk-free interest rate

 

1.9

%

Dividend yield

 

0.0

%